The AACR-Triple Negative Breast Cancer Foundation Career Development Award for Clinical/Translational Research represents a joint effort to encourage and support junior faculty to conduct triple-negative breast cancer research and establish a successful career path in this field.
“The AACR is thrilled to be collaborating with the Triple Negative Breast Cancer Foundation to offer a new grant opportunity to a promising young investigator who has the potential to make an impact for people diagnosed with triple-negative breast cancer,” said Margaret Foti, PhD, MD (hc), chief executive officer of the AACR. “Triple-negative breast cancer is a particularly aggressive form of breast cancer for which there are no personalized medicines. This career development award will help foster new research and accelerate progress against this intractable disease.”
“We share AACR’s drive to find new treatments for triple-negative breast cancer, and to diminish the threat to women diagnosed with this type of cancer,” said Hayley Dinerman, co-founder and executive director of the Triple Negative Breast Cancer Foundation.
Eligibility is limited to junior faculty who, at the start of the grant term, will have completed their most recent doctoral degree or medical residency within the past 11 years. The research proposed for funding must be clinical or translational in nature and must have direct applicability and relevance to triple-negative breast cancer.
The grant will provide $250,000 over three years, beginning July 1, 2015. The recipient will formally accept the grant at the AACR Annual Meeting 2015, held April 18-22, in Philadelphia.
Further details are available online. Applications must be submitted by noon ET, Tuesday, Jan. 27, 2015, using the proposalCENTRAL website. Additional inquiries may be directed to Ashley Jones at email@example.com.